Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
202.92B
Market cap202.92B
Price-Earnings ratio
11.04
Price-Earnings ratio11.04
Dividend yield
2.61%
Dividend yield2.61%
Average volume
16.93M
Average volume16.93M
High today
$47.49
High today$47.49
Low today
$46.73
Low today$46.73
Open price
$47.17
Open price$47.17
Volume
12.08M
Volume12.08M
52 Week high
$64.16
52 Week high$64.16
52 Week low
$35.12
52 Week low$35.12

NVO News

Nasdaq 12h
Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem

Key Points Eli Lilly should request approval for retatrutide early next year. This medicine could help the company expand the weight loss market. The drugmak...

Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem
Simply Wall St 1d
Novo Nordisk Faces A Fair Value Debate, Is It Still 55% Undervalued?

Novo Nordisk (NYSE:NVO) has drawn fresh attention after recent share price moves, with the stock closing at US$45.97. Investors are weighing this level against...

Novo Nordisk Faces A Fair Value Debate, Is It Still 55% Undervalued?
TipRanks 2d
Retail Investors Send in Sick Note for HIMS Stock Ahead of Q2 Earnings

Retail investors are feeling less healthy about the prospects of Hims & Hers (HIMS) as it gets set to report Q2 earnings next week – August 10th. Unlock powerf...

Analyst ratings

54%

of 37 ratings
Buy
37.8%
Hold
54.1%
Sell
8.1%

More NVO News

Benzinga 2d
Novo Nordisk Scores Major Court Win, Dutch Judge Halts Compounded Semaglutide Nasal Spray

Dutch judges have issued a preliminary injunction against a European compounding firm, forcing an immediate halt to sales of an unauthorized semaglutide nasal s...

Novo Nordisk Scores Major Court Win, Dutch Judge Halts Compounded Semaglutide Nasal Spray
CNBC 2d
The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

Key Points Both Eli Lilly and Novo Nordisk beat second-quarter estimates and raised their full-year outlooks. But while investors cheered Lilly's results, they...

The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings
TipRanks 2d
Novo Nordisk price target raised to $47 from $45 at BMO Capital

BMO Capital analyst Evan Seigerman raised the firm’s price target on Novo Nordisk (NVO) to $47 from $45 and keeps a Market Perform rating on the shares. Novo No...

Seeking Alpha 2d
Amazon delivers GLP-1s for $50 per month for Medicare recipients

Amazon Pharmacy (AMZN) has joined a federal program to offer GLP-1 weight-loss drugs from Novo Nordisk (NVO) and Eli Lilly (LLY) to eligible Medicare enrollees...

Amazon delivers GLP-1s for $50 per month for Medicare recipients
Simply Wall St 3d
Novo Nordisk Stock May Be Below Fair Value On ZEUS Trial Fallout

After a three year stretch where Novo Nordisk stock has declined 50.5%, the valuation picture now looks more supportive than the share price performance suggest...

Novo Nordisk Stock May Be Below Fair Value On ZEUS Trial Fallout
CNBC 3d
We're increasing our Eli Lilly price target after another beat-and-raise quarter

Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company's portfolio of GLP-1 drugs continues to...

We're increasing our Eli Lilly price target after another beat-and-raise quarter
MarketWatch 3d
How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

In August 2024, Novo Nordisk bused its employees to the sprawling Roskilde fairgrounds outside Copenhagen for its annual summer party. The Danish company had ho...

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.